National, multicentre, prospective study of quality of life in patients with osteoarthritis of the knee treated with hylane G-F 20

Clinical Rheumatology

Volumn 30, Issue 10, 2011, Pages 1285-1293

  Rat, Anne Christine ^a,b,c,d   Baumann, Cédric ^a,b,c   Guillemin, Francis ^a,b,c  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

^d CHU NANCY BRABOIS   (France)

Author keywords

Hyaluronic acid; Knee osteoarthritis; Quality of life

Indexed keywords

HYALURONIC ACID;

ADULT; AGED; ARTICLE; BACTERIAL ARTHRITIS; DEMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; EXERCISE; FEMALE; FOLLOW UP; HUMAN; IATROGENIC DISEASE; INJECTION SITE INFECTION; JOINT EFFUSION; KNEE OSTEOARTHRITIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OSTEOARTHRITIS KNEE AND HIP QUALITY OF LIFE QUESTIONNAIRE; PAIN ASSESSMENT; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VISCOSUPPLEMENTATION; VISUAL ANALOG SCALE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; BIOCOMPATIBLE MATERIALS; FEMALE; HUMANS; HYALURONIC ACID; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 80755188907     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1738-x     Document Type: Article

References (37)

1. MA Sprangers EB de Regt F Andries HM van Agt RV Bijl JB de Boer M Foets N Hoeymans AE Jacobs GI Kempen HS Miedema MA Tijhuis HC de Haes 2000 Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol 53 895 907 11004416 10.1016/S0895-4356(00)00204-3 1:STN:280: DC%2BD3M%2FhtFWrtg%3D%3D
2. PM Brooks 2002 Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications Curr Opin Rheumatol 14 573 577 12192258 10.1097/00002281-200209000-00017 (Pubitemid 34953798)
3. DJ Hawley F Wolfe 1991 Pain, disability, and pain/disability relationships in seven rheumatic disorders: a study of 1,522 patients J Rheumatol 18 1552 1557 1837315 1:STN:280:DyaK387htl2quw%3D%3D
4. JM van der Waal CB Terwee DA van der Windt LM Bouter J Dekker 2005 The impact of non-traumatic hip and knee disorders on health-related quality of life as measured with the SF-36 or SF-12. A systematic review Qual Life Res 14 1141 1155 16041909 10.1007/s11136-004-4599-9 (Pubitemid 40685237)
5. JM van der Waal CB Terwee DA van der Windt LM Bouter J Dekker 2005 Health-related and overall quality of life of patients with chronic hip and knee complaints in general practice Qual Life Res 14 795 803 16022072 10.1007/s11136-004-0801-3 (Pubitemid 40576865)
6. KM Jordan NK Arden M Doherty B Bannwarth JW Bijlsma P Dieppe K Gunther H Hauselmann G Herrero-Beaumont P Kaklamanis S Lohmander B Leeb M Lequesne B Mazieres E Martin-Mola K Pavelka A Pendleton L Punzi U Serni B Swoboda G Verbruggen I Zimmerman-Gorska M Dougados 2003 EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) Ann Rheum Dis 62 1145 1155 14644851 10.1136/ard.2003.011742 1:STN:280:DC%2BD3srpsFGmug%3D%3D (Pubitemid 37500619)
7. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines 2000 Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update Arthritis Rheum 43 1905 1915 10.1002/1529- 0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P
8. CT Wang J Lin CJ Chang YT Lin SM Hou 2004 Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials J Bone Jt Surg Am 86-A 538 545 (Pubitemid 38269025)
9. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2):CD005321
10. GH Lo M LaValley T McAlindon DT Felson 2003 Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis Jama 290 3115 3121 14679274 10.1001/jama.290.23.3115 1:CAS:528:DC%2BD3sXpvFKjtLs%3D (Pubitemid 37548117)
11. A Modawal M Ferrer HK Choi JA Castle 2005 Hyaluronic acid injections relieve knee pain J Fam Pract 54 758 767 16144589 (Pubitemid 41285757)
12. J Arrich F Piribauer P Mad D Schmid K Klaushofer M Mullner 2005 Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis CMAJ 172 1039 1043 15824412 10.1503/cmaj.1041203 (Pubitemid 40546601)
13. C Acquadro R Berzon D Dubois NK Leidy P Marquis D Revicki M Rothman 2003 Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001 Value Health 6 522 531 14627058 10.1046/j.1524-4733.2003.65309.x (Pubitemid 37187713)
14. RJ Willke LB Burke P Erickson 2004 Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels Control Clin Trials 25 535 552 15588741 10.1016/j.cct.2004.09.003 (Pubitemid 39592859)
15. JH Kellgren JS Lawrence 1957 Radiological assessment of osteo-arthrosis Ann Rheum Dis 16 494 502 13498604 10.1136/ard.16.4.494 1:STN:280: DyaG1c%2FktFeltQ%3D%3D
16. M Kosinski SD Keller HT Hatoum SX Kong JE Ware Jr 1999 The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability Med Care 37 10 22
17. O Ethgen O Bruyere F Richy C Dardennes JY Reginster 2004 Health-related quality of life in total hip and total knee arthroplasty. a qualitative and systematic review of the literature J Bone Jt Surg Am 86 963 974 (Pubitemid 38619796)
18. A Leplege E Ecosse A Verdier TV Perneger 1998 The French SF-36 health survey: translation, cultural adaptation and preliminary psychometric evaluation J Clin Epidemiol 51 1013 1023 9817119 10.1016/S0895-4356(98)00093-6 1:STN:280:DyaK1M%2Fjt1Sjuw%3D%3D (Pubitemid 28527157)
19. AC Rat J Coste J Pouchot M Baumann E Spitz N Retel-Rude JS Le Quintrec D Dumont-Fischer F Guillemin 2005 OAKHQOL: a new instrument to measure quality of life in knee and hip osteoarthritis J Clin Epidemiol 58 47 55 15649670 10.1016/j.jclinepi.2004.04.011 (Pubitemid 40093111)
20. AC Rat J Pouchot J Coste C Baumann E Spitz N Retel-Rude M Baumann JS Le Quintrec D Dumont-Fischer F Guillemin 2006 Development and testing of a specific quality-of-life questionnaire for knee and hip osteoarthritis: OAKHQOL (OsteoArthritis of Knee Hip Quality of Life) Jt Bone Spine 73 697 704 10.1016/j.jbspin.2006.01.027 (Pubitemid 44932241)
21. AC Rat F Guillemin J Pouchot 2008 Mapping the osteoarthritis knee and hip quality of life (OAKHQOL) instrument to the international classification of functioning, disability and health and comparison to five health status instruments used in osteoarthritis Rheumatol Oxf 47 1719 1725 10.1093/rheumatology/ken352
22. C Goetz E Ecosse AC Rat J Pouchot J Coste F Guillemin 2010 Measurement properties of the osteoarthritis of knee and hip quality of life (OAKHQOL): an item response theory analysis Rheumatology 50 3 500 505 21071480 10.1093/rheumatology/keq357
23. MG Lequesne C Mery M Samson P Gerard 1987 Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with other assessment tests Scand J Rheumatol Suppl 65 85 89 3479839 10.3109/ 03009748709102182 1:STN:280:DyaL1c%2FntVCltg%3D%3D
24. F Tubach P Ravaud G Baron B Falissard I Logeart N Bellamy C Bombardier D Felson M Hochberg D van der Heijde M Dougados 2005 Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state Ann Rheum Dis 64 34 37 15130902 10.1136/ard.2004.023028 1:STN:280:DC%2BD2M%2FgslKgtg%3D%3D (Pubitemid 40075271)
25. F Tubach P Ravaud G Baron B Falissard I Logeart N Bellamy C Bombardier D Felson M Hochberg D van der Heijde M Dougados 2005 Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement Ann Rheum Dis 64 29 33 15208174 10.1136/ard.2004.022905 1:STN:280:DC%2BD2M%2FgslKgtw%3D%3D (Pubitemid 40075270)
26. Ware JE, Kosinski M, Keller SK (1994) SF-36 physical and mental health summary scale: a user's manual. Boston, MA: The Health Institute
27. Insee (2008) http://www.irdesfr/EspaceRecherche/Enquetes/ EnqueteSanteSoinsMed.htm
28. JP Raynauld GW Torrance PA Band CH Goldsmith P Tugwell V Walker M Schultz N Bellamy 2002 A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): clinical results Osteoarthritis Cartilage 10 506 517 12127830 10.1053/joca.2002.0798 (Pubitemid 34919065)
29. B Mazieres H Bard M Ligier I Bru GG d'Orsay C Le Pen 2007 Medicoeconomic evaluation of hyaluronic acid for knee osteoarthritis in everyday practice: the MESSAGE study Joint Bone Spine 74 453 460 17921022 10.1016/j.jbspin.2007.01.037 (Pubitemid 47588986)
30. A Kahan PL Lleu L Salin 2003 Prospective randomized study comparing the medicoeconomic benefits of Hylan GF-20 vs. conventional treatment in knee osteoarthritis Jt Bone Spine 70 276 281 10.1016/S1297-319X(03)00043-5 (Pubitemid 37064583)
31. B Rennesson-Rey AC Rat I Chary-Valckenaere I Bettembourg-Brault N Juge H Dintinger J Pourel D Loeuille 2008 Does joint effusion influence the clinical response to a single Hylan GF-20 injection for hip osteoarthritis? Joint Bone Spine 75 182 188 18314368 10.1016/j.jbspin.2007.05.017
32. A Anandacoomarasamy H Bagga C Ding D Burkhardt PN Sambrook LM March 2008 Predictors of clinical response to intraarticular Hylan injections-a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging J Rheumatol 35 685 690 18278831 (Pubitemid 351500067)
33. T Conrozier P Mathieu AM Schott I Laurent T Hajri P Crozes P Grand H Laurent F Marchand F Meignan E Noel Y Rozand JF Savoye E Vignon 2003 Factors predicting long-term efficacy of Hylan GF-20 viscosupplementation in knee osteoarthritis Jt Bone Spine 70 128 133 10.1016/S1297-319X(03)00005-8 (Pubitemid 36528287)
34. SM Julovi T Yasuda M Shimizu T Hiramitsu T Nakamura 2004 Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage Arthritis Rheum 50 516 525 14872494 10.1002/art.20004 1:CAS:528:DC%2BD2cXhvFeiur4%3D (Pubitemid 38198835)
35. B Rennesson-Rey AC Rat I Chary-Valckenaere I Bettembourg-Brault N Juge H Dintinger J Pourel D Loeuille 2008 Does joint effusion influence the clinical response to a single Hylan GF-20 injection for hip osteoarthritis? Jt Bone Spine 75 182 188 10.1016/j.jbspin.2007.05.017
36. E Qvistgaard R Christensen S Torp-Pedersen H Bliddal 2006 Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline Osteoarthritis Cartilage 14 163 170 16290043 10.1016/j.joca.2005.09.007 1:STN:280:DC%2BD28%2FislOlsg%3D%3D (Pubitemid 43079313)
37. EM Toh PS Prasad D Teanby 2002 Correlating the efficacy of knee viscosupplementation with osteoarthritic changes on roentgenological examination Knee 9 321 330 12424042 10.1016/S0968-0160(02)00040-6 1:STN:280: DC%2BD38nmsVWgtQ%3D%3D (Pubitemid 35287533)